Latest Conference Articles

Allergan has made a name for itself in the treatment of many neurological and mental health conditions and continues to grow its portfolio. One of its newest offerings is cariprazine which they hope will be a powerful tool in the antipsychotic area.

Can any outpatient mental health program prevent all suicides in the patients it serves? An Arizona team reports success in a 90-day study.

What can a successful partnership at home mean for preventing alcohol abuse? According to one study that balance can mean the added ability to prevent a condition which can otherwise have a dramatic affect on their lives.

When wounded service members come home from war they have many areas of care that need to be addressed. Studies have shown that sexual health is an important part of the overall treatment picture.

After warmly welcoming its members to her home town, Atlanta, GA, former First Lady Rosalyn Carter brought the American Psychiatric Society up to date on her foundation's mental health advocacy successes.

Modern medicine focuses too much on extending life and too little on making sure that's the kind of life patients want. Using conversational skills like those of psychiatrists, that can change for the better.

French researchers examined several factors that could contribute to an association between antiepileptic drug use and risk of suicide attempt.

Do patients diagnosed with anxiety disorder experience a greater burden of metabolic disorders such as diabetes and hyperlipidemia?

Although Lyme disease typically impacts the skin, joints, and heart, it can also cause a variety of neurologic and psychiatric complications for which there are no current treatment guidelines.

Veterans with PTSD did better when they adopted dogs, a Texas study found.

Until recently anorexia nervosa was thought to be a problem for females only. That thinking has changed and specialists are now looking at ways to treat eating disorders in adolescent boys and men.

Buprenorphine made treatment for addiction to opioids available in a daily pill. Trial results to be presented in Atlanta, GA show an implanted form of the drug could make treatment even more convenient.

Researchers report that a complex multimodal program delivered at a dedicated facility and with a primary therapeutic focus on trauma-focused cognitive behavioral therapy appears to significantly reduce Child Post-Traumatic Stress Disorder Symptom Scale (CPPS) scores over 4 weeks.

Study results indicate that electronic health records (EHRs) appear to inadequately capture mental health diagnoses, office visits, hospitalizations, specialty care, and medications, with this missing clinical information raising concerns about medical errors and research integrity.

A group of researchers has proposed an evaluation framework to assist clinicians in evaluating the utility, safety, and efficacy of smartphone apps for psychiatry.

The findings of a systematic meta-review of 13 literature reviews examining 185 distinct studies indicates that the evidence regarding yoga as an intervention for the effects of trauma and the mental health symptoms and illnesses that frequently accompany trauma is encouraging.

Yutao Liu, MD, PhD, Georgia Regents University, discussed how he and his team can potentially target genes to either reduce glaucoma or provide neuroprotection specifically for the mitochondria in the retina.

A patch that uses patients’ own stem cells to protect them from vision loss will soon begin phase 1 trials.

Results from the ATLAS study show that patients with wet AMD treated with Eylea experienced visual and anatomic improvements after 1 year that were sustained after 2 years.

Phase 2a trial of novel topical anti-angiogenic agent regorafenib shows lack of efficacy in neovascular age-related macular degeneration.

According to Henry Kaplan, MD, University of Louisville School of Medicine, "One has to recognize that there are multiple approaches like gene therapy, neuroprotection, stem cell transplantation, and pharmacologic manipulation of other genes really holds the greatest benefit in terms of trying to reverse the inevitable loss of vision."

Henry Kaplan, MD, KY Lions Eye Center, University of Louisville School of Medicine, is focusing his efforts on figuring out how to preserve or recover lost central vision in patients with retinitis pigmentosa.

Neeraj Agarwal, PhD, FARVO, shared his unique perspective of marrying his prior clinical research to his current institutional landscape at the NIH.

Gene therapy with the CRISPR/Cas9 system corrects mutations identified with patient-specific models that use stem cells generated from skin.

Non-destructive imaging and functional assessment of retinal structures formed from human stem cells confirms their similarity to the adult retina.

Study results show that transplanted human retinal stem cells rescue photoreceptors in rabbit retinas for 8 months.

Diabetic retinapathy is one of the leading causes of blindness

Andrew Hartwick, PhD, The College of Optometry at The Ohio State University wants to understand why regardless of normal, standard vision tests, there is still clearly something wrong with pateints' sight.

Study results show that the majority of patients with retinal neovascularization due to proliferative diabetic retinopathy treated with bevacizumab experience total, long-term regression of their symptoms.

Aflibercept exerts anti-angiogenic effects against galectin-1, a galactoside-binding lectin protein and novel angiogenic factor associated with proliferative diabetic retinopathy.